pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 2,216 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
hyoscine methobromide
Methscopolamine Bromide (hyoscine methobromide [INN])
Peptic Ulcers
AACE Pharmaceuticals Inc
0 catalysts
Marketed
ibalizumab
Trogarzo (ibalizumab-uiyk)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Theratechnologies Inc
0 catalysts
Marketed
ibritumomab tiuxetan
Zevalin (ibritumomab tiuxetan)
B-Cell Non-Hodgkin Lymphoma
Acrotech Biopharma Inc
0 catalysts
← prev
page 54 of 74
next →
131
Pain89
Neurology1
Marketed
ibrutinib
Imbruvica (ibrutinib)
Follicular Lymphoma
Tyrosine-protein kinase BTK
$ABBVAbbVie Inc.
0 catalysts
Marketed
ibuprofen lysine
Neoprofen (ibuprofen lysine)
Patent Ductus Arteriosus
Recordati Rare Diseases Inc
0 catalysts
Marketed
ibutilide fumarate
Ibutilide Fumarate (ibutilide fumarate)
Atrial Fibrillation
American Regent Inc
0 catalysts
Marketed
icatibant acetate
Firazyr (icatibant acetate)
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Takeda Pharmaceuticals USA Inc
0 catalysts
Marketed
icosapent ethyl
Alfa (icosapent ethyl)
Familial Adenomatous Polyposis
KD Pharma Group SA
0 catalysts
Marketed
idarucizumab
Praxbind (idarucizumab)
Bleeding And Clotting Disorders
Boehringer Ingelheim Corp
0 catalysts
Marketed
idecabtagene vicleucel
Abecma (idecabtagene vicleucel)
Refractory Multiple Myeloma
Celgene Corp
0 catalysts
Marketed
idursulfase
Elaprase (idursulfase)
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Shire Human Genetic Therapies Inc
0 catalysts
Marketed
iloperidone
Fanapt (iloperidone)
Bipolar I Disorder
$VNDAVanda Pharmaceuticals Inc.
0 catalysts
Marketed
imipramine
Imipramine Hydrochloride (imipramine [INN])
Enuresis
Oxford Pharmaceuticals LLC
0 catalysts
Marketed
inamrinone
Amrinone Lactate (inamrinone)
Congestive Heart Failure (Heart Failure)
Hikma Pharmaceuticals USA Inc
0 catalysts
Marketed
incobotulinumtoxinA
Xeomin (incobotulinumtoxinA)
Sialorrhoea
Merz Pharmaceuticals LLC
0 catalysts
Marketed
indapamide
Indapamide (indapamide)
Edema
Rising Pharma Holdings Inc
0 catalysts
Marketed
indomethacin
Indomethacin (indomethacin)
Acute and Sub-Acute Bursitis
ACP Nimble Buyer Inc
0 catalysts
Marketed
indomethacin sodium
Indomethacin Sodium (indomethacin sodium)
Patent Ductus Arteriosus
Hikma Pharmaceuticals USA Inc
0 catalysts
Marketed
inebilizumab
Uplizna (inebilizumab)
Immunoglobulin G4-Related Disease (IgG4-RD)
Horizon Therapeutics USA Inc
0 catalysts
Marketed
infigratinib phosphate
Achondroplasia
Fibroblast growth factor receptor
QED Therapeutics Inc
0 catalysts
Marketed
infliximab
Remicade (infliximab)
Plaque Psoriasis (Psoriasis Vulgaris)
Janssen Biotech Inc
0 catalysts
Marketed
influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (quadrivalent) vaccine
Flublok Quadrivalent
Influenza A Virus, H1N1 Subtype Infections
Sanofi Pasteur Inc
0 catalysts
Marketed
influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (quadrivalent, split virion) vaccine
Flulaval Quadrivalent
Influenza A Virus, H1N1 Subtype Infections
GlaxoSmithKline Consumer Healthcare LP
0 catalysts
Marketed
influenza [strains A/H1N1 + A/H3N2 + B] (split virion) vaccine
Fluzone
Influenza A Virus, H1N1 Subtype Infections
Sanofi Pasteur Inc
0 catalysts
Marketed
influenza [strains A/H1N1 + A/H3N2 + B] (trivalent) vaccine
Flucelvax
Influenza A Virus, H1N1 Subtype Infections
Seqirus Ltd
0 catalysts
Marketed
influenza [strains A/H1N1 + A/H3N2 + B] (trivalent, split virion) vaccine
Afluria
Influenza A Virus, H1N1 Subtype Infections
Seqirus Ltd
0 catalysts
Marketed
influenza [types A and B] (quadrivalent) vaccine
Flucelvax Quadrivalent
Influenza A Virus, H1N1 Subtype Infections
Seqirus Ltd
0 catalysts
Marketed
inotuzumab ozogamicin
Besponsa (inotuzumab ozogamicin)
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
$PFEPFIZER INC
0 catalysts
Marketed
insulin degludec LA
Tresiba (insulin degludec)
Type 1 Diabetes (Juvenile Diabetes)
Novo Nordisk Inc
0 catalysts
Marketed
insulin detemir LA
Levemir (insulin detemir)
Type 1 Diabetes (Juvenile Diabetes)
Novo Nordisk Inc
0 catalysts